Immune Design
develops immunotherapy product candidates for the treatment of cancer and chronic diseases... Read moreImmune Design
develops immunotherapy product candidates for the treatment of cancer and chronic diseases... Read more
News
Apr 02, 2019
Market Exclusive
Immune Design: Immune Design Corp. (NASDAQ:IMDZ) Files An 8-K Completion of Acquisition or Disposition of Assets
Apr 02, 2019
BioSpace
Immune Design: Merck Completes Tender Offer to Acquire Immune Design
Apr 02, 2019
FirstWord Pharma
Immune Design: Merck Completes Tender Offer to Acquire Immune Design
Mar 21, 2019
4-traders
Immune Design: Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm
Mar 06, 2019
Pharmabiz
Immune Design: Merck commences tender offer to acquire Immune Design
Feb 24, 2019
BioPortfolio
Immune Design: . Merck to Acquire ImmuneDesign for $300M Boosting Immunotherapy Vaccine Pipeline httpow.lyG3z530nMN6iÂpic.twitter.compnRoSBuqLq
Feb 23, 2019
Good Stock Invest
Immune Design: Merck buys Immune Designer for Immunotherapy Developer for $ 300M - February 22, 2019
Feb 22, 2019
Zacks
Immune Design: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates
Feb 22, 2019
BioCentury
Immune Design: Merck to expand cancer vaccine tech portfolio with Immune Design bid
Feb 22, 2019
The Business Journals
Immune Design: Big Pharma rescues flailing 'cancer vaccine' company with $300 million buyout
Immune Design Competitors
1
2
3
4
5
6
7
8